David Abrams - Abrams Capital Management 13F Activity & Position Changes (Q2 2013)

As of Jun 30, 2013, the Abrams Capital Management portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 14, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q2 2013, the filing reported:

New Buys - American International Group, I, Assurant, Inc., SLM Corporation, Teva Pharmaceutical Industries , Western Union Company (The)

Increases - None reported

Reductions - None reported

Complete Exits - None reported

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q2 2013	AIG American International Group, I	American International Group, I	Buy - Position Entry	+4,745,040	-	$212.10K	4,745,040
Q2 2013	AIZ Assurant, Inc.	Assurant, Inc.	Buy - Position Entry	+1,500,000	-	$76.36K	1,500,000
Q2 2013	SLM SLM Corporation	SLM Corporation	Buy - Position Entry	+15,248,864	-	$348.59K	15,248,864
Q2 2013	TEVA Teva Pharmaceutical Industries	Teva Pharmaceutical Industries	Buy - Position Entry	+2,561,269	-	$100.40K	2,561,269
Q2 2013	WU Western Union Company (The)	Western Union Company (The)	Buy - Position Entry	+17,362,477	-	$297.07K	17,362,477